Asco21

ASCO21: Pasi A. Jänne, MD, PhD, highlights lung cancer research

Dana-Farber Cancer Institute

ASCO21: Kevin Campbell, MD, presents neuroblastoma research

Dana-Farber Cancer Institute

Yuan Yuan, M.D., Ph.D., on Breast Cancer Screenings | #ASCO21

Sumanta K. Pal, M.D. on New Study for Kidney Cancer Patients | #ASCO21

Tanya Dorff, M.D. on New Clinical Trial for Bladder Cancer | #ASCO21

ASCO21: Alison Schwartz, MS, LGC, presents on genetic variants misattributed to Li-Fraumeni syndrome

Dana-Farber Cancer Institute

What Changes Monday Morning? | Post ASCO21 Lung Cancer Panel

Total Health | Oncology

Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice Guidelines

Total Health | Oncology

Amrita Krishnan M.D., on Treatment Options for Multiple Myeloma | #ASCO21

Amrita Krishnan, M.D., Discusses a New Class of Myeloma Therapies | #ASCO21

A Message From Astellas Oncology Leadership at #ASCO21

City of Hope Patient Frank Di Bella on his Cancer Journey | #ASCO21

ASCO21 - ASCO highlights: The biggest breakthroughs; the worst setbacks - Endpoints News

ASCO21: Ann S. LaCasce, MD, MMSc presents study on PET adapted therapy in classic Hodgkin lymphoma

Dana-Farber Cancer Institute

Yuan Yuan, M.D., Ph.D., on Triple Negative Breast Cancer Treatments | #ASCO21

Leslie Popplewell, M.D., on New Mantle Cell Lymphoma Research | #ASCO21

Leslie Popplewell, M.D., on Mantle Cell Lymphoma | #ASCO21

What Changes Monday Morning? | Post ASCO21 Breast Cancer Panel

Total Health | Oncology

Gynecologic Oncology at ASCO21: Novel Targets in Recurrent Ovarian Cancer

Society of Gynecologic Oncology